Empresa Liminal BioSciences Inc. Toronto S.E.
Acciones
LMNL
CA53272L1031
Biotecnología e investigación médica
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Chief Executive Officer | 51 | 14/07/08 | |
Director of Finance/CFO | 51 | 02/03/22 | |
Patrick Sartore
PSD | President | 49 | 01/01/06 |
Gary Bridger
CTO | Chief Tech/Sci/R&D Officer | 61 | 01/05/19 |
Director/Board Member | 67 | 14/05/14 | |
Shrinal Inamdar
IRC | Investor Relations Contact | - | - |
Marie Iskra
LAW | General Counsel | 48 | 01/09/19 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Gary Bridger
CTO | Chief Tech/Sci/R&D Officer | 61 | 01/05/19 |
Director/Board Member | 67 | 14/05/14 | |
Alek Krstajic
CHM | Chairman | 60 | 01/09/20 |
Neil Klompas
BRD | Director/Board Member | 52 | 01/05/19 |
Eugene Siklos
BRD | Director/Board Member | 60 | 01/09/20 |
Director/Board Member | 63 | 01/05/19 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 3 249 534 | 1 258 903 ( 38,74 %) | 0 | 38,74 % |
Información de la empresa
Liminal BioSciences, Inc.
440, boulevard Armand-Frappier Suite 300
H7V 4B4, Laval
+450 781 0115
http://www.liminalbiosciences.comSector
Varia. 1 de ene. | Capi. | |
---|---|---|
+25,69 % | 47,9 mil M | |
+46,90 % | 41,42 mil M | |
-3,46 % | 40,7 mil M | |
-6,20 % | 28,92 mil M | |
+9,17 % | 25,55 mil M | |
-20,42 % | 19,27 mil M | |
+0,17 % | 12,15 mil M | |
+28,07 % | 12,14 mil M | |
-1,24 % | 11,99 mil M |